THERAPEUTICSMD INC (TXMD)
US88338N2062 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.05M | 4.33M | 38.10M | 64.90M | 80.50M | |||
| Receivables | 3.32M | 3.09M | N/A | 36.18M | 32.40M | |||
| Inventories | N/A | N/A | N/A | 7.62M | 8.00M | |||
| Other Current Assets | 3.78M | 4.38M | 17.30M | 54.50M | 7.50M | |||
| Total Current Assets | 12.15M | 11.80M | 55.40M | 119.50M | 128.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.30M | 6.87M | 7.70M | 9.10M | 11.50M | |||
| Intangibles | 4.43M | 6.10M | 6.90M | 7.10M | 41.40M | |||
| Other Non-Current Assets | 58.00K | 58.00K | 300.00K | 33.80M | 300.00K | |||
| Total Non-Current Assets | 27.40M | 31.51M | 35.10M | 50.00M | 53.20M | |||
| TOTAL ASSETS | 39.55M | 43.31M | 90.50M | 169.50M | 181.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 188.30M | N/A | |||
| Accrued Expenses | 2.37M | 2.72M | 17.20M | 10.50M | 26.40M | |||
| Accounts Payable | 234.00K | 27.00K | 2.20M | 3.40M | 21.10M | |||
| Other Current Liabilities | 3.37M | 4.10M | 27.40M | 50.80M | 11.70M | |||
| Total Current Liabilities | 5.98M | 6.85M | 46.80M | 252.90M | 59.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 237.70M | |||
| Other Non-Current Liabilities | 6.48M | 7.17M | 8.50M | 10.20M | 8.70M | |||
| Total Non-Current Liabilities | 6.48M | 7.17M | 8.50M | 10.20M | 246.40M | |||
| TOTAL LIABILITIES | 12.46M | 14.02M | 55.30M | 263.10M | 305.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -952.07M | -949.64M | -939.40M | -1.05B | -878.90M | |||
| Additional Paid In Capital | 979.16M | 978.92M | 974.50M | 957.70M | 754.60M | |||
| Common Shares | 11.00K | 11.00K | 0.00 | 0.00 | 300.00K | |||
| Shares Outstanding | 11.53M | 11.53M | 9.50M | 8.60M | 6.00M | |||
| Tangible Book Value per Share | 1.97 | 2.01 | 2.97 | -11.71 | -27.57 | |||
| Total Shareholders' Equity | 27.09M | 29.29M | 35.10M | -93.60M | -124.00M | |||
| TOTAL LIABILITIES AND EQUITY | 39.55M | 43.31M | 90.50M | 169.50M | 181.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -1.92 | |||
| Current Ratio | 2.03 | 1.72 | 1.18 | 0.47 | 2.17 | |||
| Return On Assets (ROA) | -8.38% | -23.73% | 123.76% | -101.72% | -101.06% | |||
| Return On Equity (ROE) | -12.24% | -35.09% | 319.09% | N/A | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 19.27% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 19.27% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 22.88% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21